Claire Villalva

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer

David Tougeron, Thierry Lecomte, Jean‐Christophe Pagès et al. · Annals of Oncology · 2013 · 110 citations · Full text

Medicine, Low-frequency Kras Mutations, Pathology +7

STAT3 is essential for the maintenance of neurosphere‐initiating tumor cells in patients with glioblastomas: A potential for targeted therapy?

Claire Villalva, Severine Martin‐Lannerée, Ulrich Cortes et al. · International Journal of Cancer · 2010 · 103 citations · Full text

Tumor Cells, Transcription Stat3, Cancer Biology +16

Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor α receptor: a new clinical target for STI571/Glivec

Pascal Trempat, Claire Villalva, Guy Laurent et al. · Oncogene · 2003 · 64 citations

Thrombosis, Blood Platelet, Hematology +8

A mesenchymal glioma stem cell profile is related to clinical outcome

Anaïs Balbous, Ulrich Cortes, Karline Guilloteau et al. · Oncogenesis · 2014 · 60 citations · Full text

Adult Stem Cell, Neural Stem Cell, Gliomasphere Initiation +21

Association between clinicopathological characteristics and RAS mutation in colorectal cancer

Johan Rimbert, Gaëlle Tachon, Audelaure Junca et al. · Modern Pathology · 2017 · 55 citations · Full text

Medicine, Genetics, Colorectal Cancer +6